- Home
- RGEN vs VFS Comparison
RGEN vs VFS Comparison
Compare RGEN & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- VFS
- Stock Information
- Founded
- RGEN 1981
- VFS 2017
- Country
- RGEN United States
- VFS Vietnam
- Employees
- RGEN N/A
- VFS N/A
- Industry
- RGEN Medical/Dental Instruments
- VFS Blank Checks
- Sector
- RGEN Health Care
- VFS Finance
- Exchange
- RGEN Nasdaq
- VFS Nasdaq
- Market Cap
- RGEN 8.0B
- VFS 8.2B
- IPO Year
- RGEN N/A
- VFS N/A
- Fundamental
- Price
- RGEN $118.10
- VFS $3.51
- Analyst Decision
- RGEN Buy
- VFS Buy
- Analyst Count
- RGEN 11
- VFS 3
- Target Price
- RGEN $169.33
- VFS $5.75
- AVG Volume (30 Days)
- RGEN 706.5K
- VFS 512.3K
- Earning Date
- RGEN 07-29-2025
- VFS 06-09-2025
- Dividend Yield
- RGEN N/A
- VFS N/A
- EPS Growth
- RGEN N/A
- VFS N/A
- EPS
- RGEN N/A
- VFS N/A
- Revenue
- RGEN $650,429,000.00
- VFS $2,103,991,902.00
- Revenue This Year
- RGEN $14.06
- VFS N/A
- Revenue Next Year
- RGEN $14.33
- VFS $40.04
- P/E Ratio
- RGEN N/A
- VFS N/A
- Revenue Growth
- RGEN 4.88
- VFS 65.72
- 52 Week Low
- RGEN $102.97
- VFS $2.56
- 52 Week High
- RGEN $182.52
- VFS $5.38
- Technical
- Relative Strength Index (RSI)
- RGEN 39.56
- VFS 48.93
- Support Level
- RGEN $123.34
- VFS $3.48
- Resistance Level
- RGEN $135.57
- VFS $3.63
- Average True Range (ATR)
- RGEN 4.62
- VFS 0.12
- MACD
- RGEN -0.33
- VFS -0.01
- Stochastic Oscillator
- RGEN 0.65
- VFS 22.58
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.